Bank of New York Mellon Corp - ADAMIS PHARMACEUTICALS CORP ownership

ADAMIS PHARMACEUTICALS CORP's ticker is ADMP and the CUSIP is 00547W208. A total of 58 filers reported holding ADAMIS PHARMACEUTICALS CORP in Q3 2021. The put-call ratio across all filers is 0.37 and the average weighting 0.0%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of ADAMIS PHARMACEUTICALS CORP
ValueSharesWeighting
Q1 2023$9,735
-31.5%
84,0020.0%0.00%
Q4 2022$14,222
-16.3%
84,0020.0%0.00%
Q3 2022$17,000
-59.5%
84,0020.0%0.00%
Q2 2022$42,000
-12.5%
84,0020.0%0.00%
Q1 2022$48,000
-5.9%
84,0020.0%0.00%
Q4 2021$51,000
-37.0%
84,0020.0%0.00%
Q3 2021$81,000
-12.0%
84,0020.0%0.00%
Q2 2021$92,000
+384.2%
84,002
+215.0%
0.00%
Q3 2019$19,000
-45.7%
26,6660.0%0.00%
Q2 2019$35,000
-37.5%
26,6660.0%0.00%
Q1 2019$56,000
-9.7%
26,666
-2.9%
0.00%
Q4 2018$62,000
-35.4%
27,4640.0%0.00%
Q3 2018$96,000
+9.1%
27,4640.0%0.00%
Q2 2018$88,000
-22.1%
27,464
-15.3%
0.00%
Q1 2018$113,000
-8.9%
32,434
+15.1%
0.00%
Q4 2017$124,000
-13.3%
28,189
+2.6%
0.00%
Q3 2017$143,000
+130.6%
27,464
+131.0%
0.00%
Q2 2017$62,000
+82.4%
11,887
+18.3%
0.00%
Q3 2016$34,000
+3.0%
10,050
-15.0%
0.00%
Q2 2016$33,000
-59.3%
11,826
-10.7%
0.00%
Q1 2016$81,000
+12.5%
13,2450.0%0.00%
Q4 2015$72,000
+41.2%
13,2450.0%0.00%
Q3 2015$51,000
-8.9%
13,2450.0%0.00%
Q2 2015$56,000
+19.1%
13,245
+11.2%
0.00%
Q1 2015$47,00011,9100.00%
Other shareholders
ADAMIS PHARMACEUTICALS CORP shareholders Q3 2021
NameSharesValueWeighting ↓
Capital CS Group, LLC 75,669$38,0000.04%
Founders Capital Management 18,000$9,0000.01%
Verdence Capital Advisors LLC 58,382$29,0000.00%
WOLFF WIESE MAGANA LLC 10,740$5,0000.00%
TWO SIGMA SECURITIES, LLC 93,669$47,0000.00%
Affinity Capital Advisors, LLC 13,180$7,0000.00%
Tower Research Capital LLC (TRC) 171,928$86,0000.00%
B. Riley Wealth Advisors, Inc. 25,210$13,0000.00%
EDMOND DE ROTHSCHILD HOLDING S.A. 100,000$50,0000.00%
MGO ONE SEVEN LLC 10,615$5,0000.00%
View complete list of ADAMIS PHARMACEUTICALS CORP shareholders